World's Best Scientists 2026 revealed!
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Medicine

D-Index
116
Citations
63344
World Ranking
4293
National Ranking
164

Ferdinand C. Breedveld publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ferdinand C. Breedveld sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 354 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ferdinand C. Breedveld D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ferdinand C. Breedveld sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Netherlands Leader Award

Overview

Ferdinand C. Breedveld is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on the field of Medicine, with a significant emphasis on Rheumatology. Other subfields of study include Hematology, Genetics, and Pathology and Forensic Medicine.

The main topics of their work cover a range of areas within medical research, including:

  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Spondyloarthritis Studies and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment

Breedveld has published in notable venues related to their fields of study. Frequent publication venues are:

  • Annals of the Rheumatic Diseases
  • The Open Rheumatology Journal

Recent papers authored or co-authored by Breedveld include:

  • "Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023" (2023), published in Annals of the Rheumatic Diseases
  • "Clinical, Radiologic, and Functional Outcomes Following Methotrexate Withdrawal in Etanercept-Treated Patients with Active Early Rheumatoid Arthritis: A Subanalysis of COMET Year 2 by Week 52 DAS28 Status" (2021), published in The Open Rheumatology Journal

Breedveld collaborates with several frequent co-authors in their research work. These include:

  • Kevin Winthrop
  • Philip J. Mease
  • Andreas Kerschbaumer
  • Reinhard Voll
  • Josef S Smolen

Their research contributions span clinical and translational aspects of rheumatology and related autoimmune diseases, focusing on disease mechanisms and therapeutic strategies. The involvement in studies related to rheumatoid arthritis and inflammatory disorders is notable in their publication record.

Best Publications

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

    G.A. Schellekens;H.K.A. Visser;B.A.W. de Jong;F.H.J. van den Hoogen

  • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

    Ferdinand C Breedveld;Michael H Weisman;Arthur F Kavanaugh;Stanley B Cohen

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

    Ravinder N. Maini;Ferdinand C. Breedveld;Joachim R. Kalden;Josef S. Smolen

  • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

    Y. P. M. Goekoop-Ruiterman;J. K. De Vries-Bouwstra;C. F. Allaart;D. Van Zeben

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • A simplified disease activity index for rheumatoid arthritis for use in clinical practice

    J.S. Smolen;F.C. Breedveld;M.H. Schiff;J.R. Kalden

  • Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

    Paul Emery;Ferdinand C Breedveld;Stephen Hall;Patrick Durez

  • How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

    Henk Visser;Saskia le Cessie;Koen Vos;Ferdinand C. Breedveld

  • Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

    F.A. van Gaalen;S.P. Linn-Rasker;W.J.W. van Venrooij;B.A. de Jong

  • Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies

    Leroy R Lard;Henk Visser;Irene Speyer;Irene E vander Horst-Bruinsma

  • Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.

    Tom W. J. Huizinga;Christopher I. Amos;Annette H. M. van der Helm-van Mil;Wei Chen

  • The Safety and Efficacy of a JAK Inhibitor in Patients With Active Rheumatoid Arthritis Results of a Double-Blind, Placebo-Controlled Phase IIa Trial of Three Dosage Levels of CP-690,550 Versus Placebo

    Joel M. Kremer;Bradley J. Bloom;Ferdinand C. Breedveld;John H. Coombs

  • Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

    Peter Charles;Michael J. Elliott;Diana Davis;Alison Potter

  • Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity

    P. P. Tak;T. J. M. Smeets;M. R. Daha;P. M. Kluin

  • Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

    Annette H M van der Helm-van Mil;Kirsten N Verpoort;Ferdinand C Breedveld;René E M Toes

  • A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis

    P Emery;F C Breedveld;E M Lemmel;J P Kaltwasser

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

Frequent Co-Authors

Paul Emery
Paul Emery University of Leeds
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Tom W. J. Huizinga
Tom W. J. Huizinga Leiden University Medical Center
Ben A. C. Dijkmans
Ben A. C. Dijkmans Amsterdam UMC
Maxime Dougados
Maxime Dougados Hôpital Cochin
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Tore K. Kvien
Tore K. Kvien University of Oslo
Margreet Kloppenburg
Margreet Kloppenburg Leiden University Medical Center
Robert Landewé
Robert Landewé University of Amsterdam
Josef S. Smolen
Josef S. Smolen Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring a career in medicine but want flexibility, various online programs can help you advance without disrupting your current commitments. For those aiming for healthcare leadership, cahme accredited online mha programs offer a rigorous curriculum tailored for future administrators, ensuring high-quality standards recognized in the industry.

Registered Nurses looking to elevate their qualifications can benefit from convenient rn to bsn online no clinicals accredited programs—ideal for those wanting to upgrade without additional clinical requirements. For nurses striving for advanced practice or leadership roles, accelerated options like short dnp programs can quickly lead to a Doctor of Nursing Practice degree, helping you fast-track your expertise.

Flexibility remains a key advantage, especially with diverse dnp online programs now available for a variety of learning needs and backgrounds. Each pathway provides opportunities to shape your medical career with accredited, reputable education at your own pace.

Best Scientists Citing Ferdinand C. Breedveld

Trending Scientists

Recently Published Articles